Nymox Pharmaceutical Corporation news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

NYMX 0.400 0.000 (0.07%)
price chart
Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation ...
PHILADELPHIA, Nov. 26, 2014 /PRNewswire/ -- Cohen, Placitella & Roth, PC is investigating potential claims on behalf of investors who purchased Nymox Pharmaceutical Corporation ("Nymox" or "Company") NYMX, +6.62% during the period from January ...
Related articles »  
EQUITY ALERT: Rosen Law Firm Reminds Nymox Pharmaceutical Corporation ...
NEW YORK, Dec. 12, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm reminds purchasers of Nymox Pharmaceutical Corporation common stock (Nasdaq:NYMX) during the period from January 31, 2011 through November 2, 2014, of the important ...
Related articles »  
Here's Why Nymox Nosedived Yesterday
Nymox Pharmaceutical Corporation (NYMX) was one of the biggest losers in the biotech sector yesterday, as its stock plunged almost 82% on news that the company's key drug candidate was unsuccessful in two late-stage trials.
Nymox Pharma (NYMX) Phase 3 Studies of NX-1207 Fail to Meet Primary ...  StreetInsider.com (subscription)
Nymox NX-1207 BPH Pivotal Phase 3 U.S. Studies NX02-0017 and NX02-0018 ...  GlobeNewswire (press release)
Related articles »  
Class Action Lawsuit Filed Against Nymox Pharmaceutical Corporation and Paul ...
PHILADELPHIA, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Law Offices Bernard M. Gross, P.C. filed a class action lawsuit in the United States District Court, District of New Jersey, 14-cv-07331, on behalf of purchasers of NYMOX common stock between January ...
Overreliance on it can be a major problem  Nasdaq
Related articles »  
Rosen Law Firm Reminds Nymox Pharmaceutical Corporation Investors of ...
The Rosen Law Firm reminds purchasers of Nymox Pharmaceutical Corporation common stock NYMX, +4.25% during the period from January 31, 2011 through November 2, 2014, of the important January 26, 2015 lead plaintiff deadline in the class action.
Robbins Arroyo LLP: Nymox Pharmaceutical Corporation (NYMX) Misled ...
SAN DIEGO and QUEBEC, Canada, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Nymox Pharmaceutical Corporation (Nasdaq:NYMX) has filed a federal securities fraud class action ...
Related articles »  
Monday Hot Stock List: Nymox Pharmaceutical Corporation (NYMX), Central ...
Nymox Pharmaceutical Corporation (NYMX) closed the session Friday at $0.42, a gain of 4.25% trading at a volume of 135,028 shares.
Stocks Appreciate for the Week: Heico Corp , Nymox Pharmaceutical Corp  Winston View
Market Movers: Caterpillar Inc. (NYSE:CAT), JD.com (NASDAQ:JD), Nymox ...  Property Mentor
Nymox Announces $1.07 Million Financing
HASBROUCK HEIGHTS, N.J., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today the closing of U.S.
Related articles »  
Worst Year-To-Date Performers: Nymox Pharmaceutical Corporation (NASDAQ ...
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has YTD performance of -87.97%. The company has the market capitalization of $ 29.85M.
Related articles »  
Worst Year-To-Date Performers: FreeSeas Inc (NASDAQ:FREE), Nymox ...
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has booked the year to date performance of -86.49% while its market capitalization stands at $ 32.91M.